Advances in nanomaterial-based immunosensors for prostate cancer screening

Rabia Khan; Fareeha Arshad; Israr U Hassan; Gowhar A Naikoo; Mona Z Pedram; Mohammed Saeedi Zedegan; Hamed Pourfarzad; Alaa A A Aljabali; Ángel Serrano-Aroca; Yusuf Haggag; Vijay Mishra; Yachana Mishra; Martin Birkett; Murtaza M Tambuwala

doi:10.1016/j.biopha.2022.113649

Advances in nanomaterial-based immunosensors for prostate cancer screening

Rabia Khan, Fareeha Arshad, Israr U Hassan, Gowhar A Naikoo, Mona Z Pedram, Mohammed Saeedi Zedegan, Hamed Pourfarzad, Alaa A A Aljabali, Ángel Serrano-Aroca, Yusuf Haggag, Vijay Mishra, Yachana Mishra, Martin Birkett, Murtaza M Tambuwala

Research output: Contribution to journal › Review article › peer-review

8 Citations (Scopus)

64 Downloads (Pure)

Abstract

Prostate cancer is one of the most common health hazards for men worldwide, specifically in Western countries. Rapid prostate cancer screening by analyzing the prostate-specific antigen present in male serum has brought about a sharp decline in the mortality index of this disease. Immunoassay technology quantifies the target analyte in the sample using the antigen-antibody reaction. Immunoassays are now pivotal in disease diagnostics, drug monitoring, and pharmacokinetics. Recently, immunosensors have gained momentum in delivering better results with high specificity and lower limit of detection (LOD). Nanomaterials like gold, silver, and copper exhibit numerous exceptional features and their use in developing immunosensors have garnered excellent results in the diagnostic field. This review highlights the recent and different immunoassay techniques used to detect prostate-specific antigens and discusses the advances in nanomaterial-based immunosensors to detect prostate cancer efficiently. The review also explores the importance of specific biomarkers and nanomaterials-based biosensors with good selectivity and sensitivity to prostate cancer.

Original language	English
Article number	113649
Pages (from-to)	1-12
Number of pages	12
Journal	Biomedicine and Pharmacotherapy
Volume	155
Early online date	13 Sept 2022
DOIs	https://doi.org/10.1016/j.biopha.2022.113649
Publication status	Published (in print/issue) - 1 Nov 2022

Bibliographical note

Funding Information:
G. A. Naikoo, I. U. Hassan acknowledge the support provided by the Dhofar University, Salalah, Oman.

Publisher Copyright:
© 2022 The Authors

Copyright © 2022 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Keywords

Nanomaterials
Metallic nanomaterials
Prostate-specific antigen
Prostate cancer
Immunosensors
Gold
Early Detection of Cancer
Immunoassay/methods
Biosensing Techniques/methods
Humans
Male
Nanostructures
Silver
Prostatic Neoplasms/diagnosis
Biomarkers
Electrochemical Techniques/methods
Copper

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.biopha.2022.113649

1-s2.0-S0753332222010381-mainFinal published version, 8.86 MBLicence: CC BY

Cite this

Khan, R., Arshad, F., Hassan, I. U., Naikoo, G. A., Pedram, M. Z., Zedegan, M. S., Pourfarzad, H., Aljabali, A. A. A., Serrano-Aroca, Á., Haggag, Y., Mishra, V., Mishra, Y., Birkett, M., & Tambuwala, M. M. (2022). Advances in nanomaterial-based immunosensors for prostate cancer screening. Biomedicine and Pharmacotherapy, 155, 1-12. Article 113649. Advance online publication. https://doi.org/10.1016/j.biopha.2022.113649

@article{25d258dc22a44c4191bfcbfbc0eac51d,

title = "Advances in nanomaterial-based immunosensors for prostate cancer screening",

abstract = "Prostate cancer is one of the most common health hazards for men worldwide, specifically in Western countries. Rapid prostate cancer screening by analyzing the prostate-specific antigen present in male serum has brought about a sharp decline in the mortality index of this disease. Immunoassay technology quantifies the target analyte in the sample using the antigen-antibody reaction. Immunoassays are now pivotal in disease diagnostics, drug monitoring, and pharmacokinetics. Recently, immunosensors have gained momentum in delivering better results with high specificity and lower limit of detection (LOD). Nanomaterials like gold, silver, and copper exhibit numerous exceptional features and their use in developing immunosensors have garnered excellent results in the diagnostic field. This review highlights the recent and different immunoassay techniques used to detect prostate-specific antigens and discusses the advances in nanomaterial-based immunosensors to detect prostate cancer efficiently. The review also explores the importance of specific biomarkers and nanomaterials-based biosensors with good selectivity and sensitivity to prostate cancer.",

keywords = "Nanomaterials, Metallic nanomaterials, Prostate-specific antigen, Prostate cancer, Immunosensors, Gold, Early Detection of Cancer, Immunoassay/methods, Biosensing Techniques/methods, Humans, Male, Nanostructures, Silver, Prostatic Neoplasms/diagnosis, Biomarkers, Electrochemical Techniques/methods, Copper",

author = "Rabia Khan and Fareeha Arshad and Hassan, {Israr U} and Naikoo, {Gowhar A} and Pedram, {Mona Z} and Zedegan, {Mohammed Saeedi} and Hamed Pourfarzad and Aljabali, {Alaa A A} and {\'A}ngel Serrano-Aroca and Yusuf Haggag and Vijay Mishra and Yachana Mishra and Martin Birkett and Tambuwala, {Murtaza M}",

note = "Funding Information: G. A. Naikoo, I. U. Hassan acknowledge the support provided by the Dhofar University, Salalah, Oman. Publisher Copyright: {\textcopyright} 2022 The Authors Copyright {\textcopyright} 2022 The Authors. Published by Elsevier Masson SAS.. All rights reserved.",

year = "2022",

month = nov,

day = "1",

doi = "10.1016/j.biopha.2022.113649",

language = "English",

volume = "155",

pages = "1--12",

journal = "Biomedicine and Pharmacotherapy",

issn = "0753-3322",

publisher = "Elsevier",

}

TY - JOUR

T1 - Advances in nanomaterial-based immunosensors for prostate cancer screening

AU - Khan, Rabia

AU - Arshad, Fareeha

AU - Hassan, Israr U

AU - Naikoo, Gowhar A

AU - Pedram, Mona Z

AU - Zedegan, Mohammed Saeedi

AU - Pourfarzad, Hamed

AU - Aljabali, Alaa A A

AU - Serrano-Aroca, Ángel

AU - Haggag, Yusuf

AU - Mishra, Vijay

AU - Mishra, Yachana

AU - Birkett, Martin

AU - Tambuwala, Murtaza M

N1 - Funding Information: G. A. Naikoo, I. U. Hassan acknowledge the support provided by the Dhofar University, Salalah, Oman. Publisher Copyright: © 2022 The Authors Copyright © 2022 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

PY - 2022/11/1

Y1 - 2022/11/1

N2 - Prostate cancer is one of the most common health hazards for men worldwide, specifically in Western countries. Rapid prostate cancer screening by analyzing the prostate-specific antigen present in male serum has brought about a sharp decline in the mortality index of this disease. Immunoassay technology quantifies the target analyte in the sample using the antigen-antibody reaction. Immunoassays are now pivotal in disease diagnostics, drug monitoring, and pharmacokinetics. Recently, immunosensors have gained momentum in delivering better results with high specificity and lower limit of detection (LOD). Nanomaterials like gold, silver, and copper exhibit numerous exceptional features and their use in developing immunosensors have garnered excellent results in the diagnostic field. This review highlights the recent and different immunoassay techniques used to detect prostate-specific antigens and discusses the advances in nanomaterial-based immunosensors to detect prostate cancer efficiently. The review also explores the importance of specific biomarkers and nanomaterials-based biosensors with good selectivity and sensitivity to prostate cancer.

AB - Prostate cancer is one of the most common health hazards for men worldwide, specifically in Western countries. Rapid prostate cancer screening by analyzing the prostate-specific antigen present in male serum has brought about a sharp decline in the mortality index of this disease. Immunoassay technology quantifies the target analyte in the sample using the antigen-antibody reaction. Immunoassays are now pivotal in disease diagnostics, drug monitoring, and pharmacokinetics. Recently, immunosensors have gained momentum in delivering better results with high specificity and lower limit of detection (LOD). Nanomaterials like gold, silver, and copper exhibit numerous exceptional features and their use in developing immunosensors have garnered excellent results in the diagnostic field. This review highlights the recent and different immunoassay techniques used to detect prostate-specific antigens and discusses the advances in nanomaterial-based immunosensors to detect prostate cancer efficiently. The review also explores the importance of specific biomarkers and nanomaterials-based biosensors with good selectivity and sensitivity to prostate cancer.

KW - Nanomaterials

KW - Metallic nanomaterials

KW - Prostate-specific antigen

KW - Prostate cancer

KW - Immunosensors

KW - Gold

KW - Early Detection of Cancer

KW - Immunoassay/methods

KW - Biosensing Techniques/methods

KW - Humans

KW - Male

KW - Nanostructures

KW - Silver

KW - Prostatic Neoplasms/diagnosis

KW - Biomarkers

KW - Electrochemical Techniques/methods

KW - Copper

UR - http://www.scopus.com/inward/record.url?scp=85137659800&partnerID=8YFLogxK

U2 - 10.1016/j.biopha.2022.113649

DO - 10.1016/j.biopha.2022.113649

M3 - Review article

C2 - 36108389

SN - 0753-3322

VL - 155

SP - 1

EP - 12

JO - Biomedicine and Pharmacotherapy

JF - Biomedicine and Pharmacotherapy

M1 - 113649

ER -

Advances in nanomaterial-based immunosensors for prostate cancer screening

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this